Yahoo Finance

RepliCel Reports Progress on Shiseido Technology Transfer for RCH-01 Treatment for Pattern Baldness

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec 19, 2013) - RepliCel Life Sciences Inc. (REPCF)(CNSX:RP) today reported on the progress of its technology transfer agreement with its partner, Shiseido ...
Yahoo UK & Ireland

RepliCel to Present RCH-01 Phase 1 Clinical Data at the 13th Congress of the Japanese Society for Regenerative Medicine

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb 27, 2014) - RepliCel Life Sciences Inc. (REPCF) (TSX VENTURE:RP) announced that its Director of Research and Development, Dr. Hisae Nakamura, and its ...
Yahoo Finance

RepliCel Life Sciences' Licensing Partner, Shiseido, Opens Cell Processing and Expansion Facility in Japan to Advance RCH-01, a Treatment for Pattern Baldness

VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 20, 2014) - RepliCel Life Sciences Inc. (REPCF)(TSX VENTURE:RP) a clinical stage regenerative medicine company focused on the development of autologous ...
Yahoo! Sports

RepliCel Completes First Pre-Filing Review with German Competent Authority on its RCH-01 Autologous Hair Cell Manufacturing Process

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov 7, 2012) - RepliCel Life Sciences Inc. (REPCF) (the "Company" or "RepliCel") is pleased to report on its pre-filing scientific meeting with the German ...